Bronchiectasis Epidemiology and Risk Factors
Purpose of Review The purpose of this review article was to understand the global trends in bronchiectasis, understand the risk factors and appreciate the role of comorbidities in bronchiectasis. Recent Findings The burden of bronchiectasis has been increasing globally over the last decade. Data from national registries suggest geographical variations in aetiology and prevalence, which has further led to the creation of national guidelines for the management of bronchiectasis. Comorbidities play an important role in the prognosis, with some playing a direct role in disease development and progression. Systemic and airway inflammation seems to be the main link between comorbidities and bronchiectasis. Various predictive scores have been developed to determine the prognosis of bronchiectasis. As there is a significant geographical variation in the aetiology, epidemiology, microbiology and severity of bronchiectasis, the appropriate prognostication score needs to be chosen and validated in the local population. Summary The geographical variation in the aetiology, pattern and distribution of bronchiectasis alludes to the need for developing clinical guidelines for the local population. As comorbidities have shown to affect the prognosis, personalised medicine treating bronchiectasis as well as the comorbidities, seems to be the way forward..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Current respiratory care reports - 12(2023), 3 vom: 06. Juli, Seite 97-104 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Krishnan, Shyam [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Bronchiectasis |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
|---|
| doi: |
10.1007/s13665-023-00317-w |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR052580776 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR052580776 | ||
| 003 | DE-627 | ||
| 005 | 20230730064711.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230730s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s13665-023-00317-w |2 doi | |
| 035 | |a (DE-627)SPR052580776 | ||
| 035 | |a (SPR)s13665-023-00317-w-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Krishnan, Shyam |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Bronchiectasis Epidemiology and Risk Factors |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
| 520 | |a Purpose of Review The purpose of this review article was to understand the global trends in bronchiectasis, understand the risk factors and appreciate the role of comorbidities in bronchiectasis. Recent Findings The burden of bronchiectasis has been increasing globally over the last decade. Data from national registries suggest geographical variations in aetiology and prevalence, which has further led to the creation of national guidelines for the management of bronchiectasis. Comorbidities play an important role in the prognosis, with some playing a direct role in disease development and progression. Systemic and airway inflammation seems to be the main link between comorbidities and bronchiectasis. Various predictive scores have been developed to determine the prognosis of bronchiectasis. As there is a significant geographical variation in the aetiology, epidemiology, microbiology and severity of bronchiectasis, the appropriate prognostication score needs to be chosen and validated in the local population. Summary The geographical variation in the aetiology, pattern and distribution of bronchiectasis alludes to the need for developing clinical guidelines for the local population. As comorbidities have shown to affect the prognosis, personalised medicine treating bronchiectasis as well as the comorbidities, seems to be the way forward. | ||
| 650 | 4 | |a Bronchiectasis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Epidemiology |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Risk factors |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Comorbidities |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Prognosis |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Dhar, Raja |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current respiratory care reports |d New York, NY : Springer, 2012 |g 12(2023), 3 vom: 06. Juli, Seite 97-104 |w (DE-627)SPR032139020 |w (DE-600)2660484-X |x 2161-332X |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2023 |g number:3 |g day:06 |g month:07 |g pages:97-104 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s13665-023-00317-w |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2023 |e 3 |b 06 |c 07 |h 97-104 | ||